期刊
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
卷 14, 期 5, 页码 233-239出版社
SAGE PUBLICATIONS INC
DOI: 10.2310/7750.2010.09049
关键词
-
类别
资金
- Ortho Biotech Canada
- Abbott
- Amgen-Wyeth
- Astellas Inc
- Centocor Inc
- EMD Serono
- Schering-Plough
- Janssen Ortho
- Galderma
- Leo
- Janssen-Ortho
- Bristol Myers Squibb
- Steifel
Background: Informed shared decision making is a mutual process engaging both doctor and patient and informed by best medical evidence and patient values and preferences. Objective: Our aim was to identify the needs of psoriasis patients in decisions on selecting treatment Methods: Psoriasis subjects participated in an online survey on decisional role, postdecisional conflict, and treatment awareness Results: Of 2,622 people invited to participate, 248 completed surveys. Their most recent treatment decision was either made by subjects alone (42%) or physicians alone (28%) or was shared (29%) Subjects perceived that their doctors lacked time to stay abreast of treatments, to provide counseling, and to access appropriate treatments. Deficiencies most frequently identified were information on options, clarification of values, access to physicians, and decision-making skills. Those with a body surface area (BSA) >= 3% more frequently indicated that having the skill or ability to make treatment decisions was important. Limitations: The limitations of this study include sampling, recall, and reporting bias Percent BSA was not verified. Conclusions: The multiple deficiencies in support of psoriasis patients in treatment decisions may preclude informed shared decision making
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据